Back to results
US 11,890,319 B2Granted
Antibody molecule-drug conjugates and uses thereof
AssigneeVisterra, Inc.
InventorsZachary Shriver, Obadiah Joseph Plante, Kai Li, Karthik Viswanathan, James C. Delaney, Boopathy Ramakrishnan, Andrew M. Wollacott
Life of this patent
Estimating the term…
Abstract
Antibody molecule-drug conjugates (ADCs) that specifically bind to lipopolysaccharides (LPS) are disclosed. The antibody molecule-drug conjugates can be used to treat, prevent, and/or diagnose bacterial infections and related disorders.
Claims23
An antibody molecule-drug conjugate (ADC) comprising an anti-LPS antibody molecule and a covalently coupled antimicrobial peptide, wherein the antibody molecule comprises one or more motifs, wherein:
- (I) the one or more motifs have the formula:
- X1(FGly′)X2Z2X3Z3
- wherein FGly′ is a 2-formylglycine residue, a cysteine, or a serine;
- Z2 is a proline or alanine residue;
- X1, X2, and X3 are each independently any amino acid;
- Z3 is a basic amino acid;
- and
- (II) the antibody molecule comprises:
- (i) a heavy chain comprising a heavy chain variable region (VH) comprising:
- (a) an HCDR1 comprising the amino acid sequence of SEQ ID NO:
- 108, an HCDR2 comprising the amino acid sequence of SEQ ID NO:
- 146, and an HCDR3 comprising the amino acid sequence of SEQ ID NO:
- 107;
- or
- (b) an HCDR1 comprising the amino acid sequence of SEQ ID NO:
- 105, an HCDR2 comprising the amino acid sequence of SEQ ID NO:
- 106, and an HCDR3 comprising the amino acid sequence of SEQ ID NO:
- 107;
- and/or
- (ii) a light chain comprising a light chain variable region (VL) comprising:
- an LCDR1 comprising the amino acid sequence of SEQ ID NO:
- 138, an LCDR2 comprising the amino acid sequence of SEQ ID NO:
- 142, and an LCDR3 comprising the amino acid sequence of any of SEQ ID NO:
- 112;
- and
- (III) the antimicrobial peptide comprises the amino acid sequence of GGGKFFRKLKKSVKKRAKEFFKKPRVIGVSIPF (SEQ ID NO:
- 156).
24 more elements
Dependencies are inferred from the claim text.